NanoVibronix Receives Wound Healing Indications in Europe for its PainShield(TM) Device

NESHER, Israel, April 21 /PRNewswire/ -- NanoVibronix, a medical device company specializing in applications that implement surface ultrasound waves, announced that its novel device has received CE approval in Europe for additional claims of wound healing. PainShield is the first hands-free, patch-based device that uses surface ultrasound waves for therapeutic treatment of wounds. The innovative PainShield consists of a disposable patch connected to a portable driver. PainShield for wound therapy will be introduced at the upcoming European Wound Management Association (EWMA) conference in Helsinki, Finland on May 20 - 22, 2009.

"My experience with PainShield has shown that it is one of the most striking therapeutic modalities in chronic wound care. PainShield implements the benefits of ultrasound to enhance the therapeutic processes required for chronic wound healing, and has shown to do that repeatedly both in the clinical and home setting. ", stated Dr. Jonathan Rosenblum, Director, Diabetic Foot Service, Shaare Zedek Medical Center, Jerusalem, Israel. Dr. Rosenblum will be presenting his experience with PainShield for chronic wounds at the International Conference of Dermatology (ICD), Prague, Czech Republic on May 20 - 24, 2009.

Dr. Leon Gilad, Chief of Wound Care at Hadassah University Medical Center, Jerusalem, Israel, said, "The beneficial properties of low frequency, low intensity ultrasound in a compact, convenient patch allows for a whole new dimension in wound therapy. The ability to place the PainShield patch on healthy skin adjacent to the wound allows the ongoing wound care to continue uninterrupted, while therapeutic ultrasound is provided simultaneously to the wound site. In addition to the wound healing benefits of the PainShield, we have seen a dramatic diminishing of wound pain when pain was present."

NanoVibronix CEO, Dr. Harold Jacob, added, "PainShield, which implements our unique low frequency ultrasound platform, has been shown in a number of independent studies to have powerful tissue regenerative properties. NanoVibronix has created a platform that allows physicians to easily apply therapeutic ultrasound to assist in wound healing without interfering with any of the other modalities that are being utilized. Our simple-to-use, portable patch-based device can treat wounds in the hospital or at home, allowing patients to continue with their daily activities."

About the Company

NanoVibronix, located in Nesher Israel, develops medical devices that implement its proprietary therapeutic ultrasound technology. The innovative portable PainShield device for treatment of pain gained FDA clearance in October 2008. The Company is planning to launch the product in the USA during the second half of 2009. The company has also developed a unique line of catheter-based disposable ultrasound devices designed to treat catheter associated injury including pain, discomfort and biofilm formation. The first two products in this family are the UroShield(TM) for indwelling urinary catheters and the NG-Shield(TM) for indwelling Nasogastric tubes.

http://www.nanovibronix.com

For more information, please contact:

Amir Rippel, VP Marketing NanoVibronix Ltd. Tel: +972-4-820-0581 Fax: +972-4-820-2794 info@nanovibronix.com